reyvow

Generic: lasmiditan

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name reyvow
Generic Name lasmiditan
Labeler eli lilly and company
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lasmiditan 50 mg/1

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-4312
Product ID 0002-4312_75a13e98-3736-4256-8277-6c05bcaddcf5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA211280
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2019-10-11

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00024312
Hyphenated Format 0002-4312

Supplemental Identifiers

RxCUI
2256937 2256943 2256945 2256947
UPC
0300024491083
UNII
760I9WM792

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name reyvow (source: ndc)
Generic Name lasmiditan (source: ndc)
Application Number NDA211280 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 2 BLISTER PACK in 1 CARTON (0002-4312-08) / 4 TABLET in 1 BLISTER PACK
  • 1 BLISTER PACK in 1 CARTON (0002-4312-61) / 4 TABLET in 1 BLISTER PACK
  • 1 BLISTER PACK in 1 CARTON (0002-4312-62) / 2 TABLET in 1 BLISTER PACK
source: ndc

Packages (3)

Ingredients (1)

lasmiditan (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "75a13e98-3736-4256-8277-6c05bcaddcf5", "openfda": {"upc": ["0300024491083"], "unii": ["760I9WM792"], "rxcui": ["2256937", "2256943", "2256945", "2256947"], "spl_set_id": ["aea3358c-ff41-4490-9e6d-c7bf7b3de13f"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (0002-4312-08)  / 4 TABLET in 1 BLISTER PACK", "package_ndc": "0002-4312-08", "marketing_start_date": "20200131"}, {"sample": true, "description": "1 BLISTER PACK in 1 CARTON (0002-4312-61)  / 4 TABLET in 1 BLISTER PACK", "package_ndc": "0002-4312-61", "marketing_start_date": "20210303"}, {"sample": true, "description": "1 BLISTER PACK in 1 CARTON (0002-4312-62)  / 2 TABLET in 1 BLISTER PACK", "package_ndc": "0002-4312-62", "marketing_start_date": "20220228"}], "brand_name": "Reyvow", "product_id": "0002-4312_75a13e98-3736-4256-8277-6c05bcaddcf5", "dosage_form": "TABLET", "product_ndc": "0002-4312", "dea_schedule": "CV", "generic_name": "lasmiditan", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Reyvow", "active_ingredients": [{"name": "LASMIDITAN", "strength": "50 mg/1"}], "application_number": "NDA211280", "marketing_category": "NDA", "marketing_start_date": "20191011", "listing_expiration_date": "20261231"}